Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Seminars in Radiation Oncology
|
April 10, 1999
Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy
B A Fraass, M L Kessler, D L McShan, et al.
Medical Physics
|
March 29, 2007
Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions
Aaron C Spalding, Kyung-Wook Jee, Karen Vineberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 10, 2001
Planning, computer optimization, and dosimetric verification of a segmented irradiation technique for prostate cancer
E M Damen, M J Brugmans, A van der Horst, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 14, 1999
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
M K Martel, R K Ten Haken, M B Hazuka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1989
A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning
S L Schoeppel, B A Fraass, M P Hopkins, et al.
Advances in Radiation Oncology
|
January 26, 2022
Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis
Christopher Gay, Yaniv R Raphael, Jennifer Steers, et al.
Acta Cardiologica
|
April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study
Klaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies
Klaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Journal of Applied Clinical Medical Physics
|
December 25, 2015
AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams
Jennifer B Smilowitz, Indra J Das, Vladimir Feygelman, et al.
Practical Radiation Oncology
|
November 22, 2014
Practice patterns for peer review in radiation oncology
David J Hoopes, Peter A Johnstone, Patrick S Chapin, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Seminars in Radiation Oncology
|
April 10, 1999
Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy
B A Fraass, M L Kessler, D L McShan, et al.
Medical Physics
|
March 29, 2007
Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions
Aaron C Spalding, Kyung-Wook Jee, Karen Vineberg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 10, 2001
Planning, computer optimization, and dosimetric verification of a segmented irradiation technique for prostate cancer
E M Damen, M J Brugmans, A van der Horst, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 14, 1999
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
M K Martel, R K Ten Haken, M B Hazuka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1989
A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning
S L Schoeppel, B A Fraass, M P Hopkins, et al.
Advances in Radiation Oncology
|
January 26, 2022
Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis
Christopher Gay, Yaniv R Raphael, Jennifer Steers, et al.
Acta Cardiologica
|
April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS study
Klaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies
Klaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Journal of Applied Clinical Medical Physics
|
December 25, 2015
AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams
Jennifer B Smilowitz, Indra J Das, Vladimir Feygelman, et al.
Practical Radiation Oncology
|
November 22, 2014
Practice patterns for peer review in radiation oncology
David J Hoopes, Peter A Johnstone, Patrick S Chapin, et al.
Page
of 18